cd19-cd34 car transduced t cells
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2019 (NCT04214886)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- B-lymphocyte antigen CD19Immunity, passive
CD19 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05702853 | Phase 1/Phase 2 (Phase 2) | Nov 6, 2023 | Medical University of South Carolina |
| NCT04214886 | Phase 1 | Dec 31, 2019 | Leukemia Research Foundation, Loyola University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Leukemia Research Foundation | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Loyola University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Medical University of South Carolina | Academic/Hospital | 1 | 1 | 1 | 2023 |
3 organizations
Page 1 / 1